FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
AALTO SCIENTIFIC LTD. GLYCATED HEMOGLOBIN CONTROL LEVELS I & II
K Number: K952720
·
Decision Sep 20, 1995
Classifications
1
FEI Numbers
32
Registration Numbers
32
Same Product Code
191
Applicant Total
35
Review Days
97
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- AALTO SCIENTIFIC LTD. GLYCATED HEMOGLOBIN CONTROL LEVELS I & II
- K Number
- K952720
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 864.8625
- Medical Specialty
- Hematology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Aalto Scientific, Ltd.
- Date Received
- June 15, 1995
- Decision Date
- September 20, 1995
- Product Code
- JPK
- Advisory Committee
- Hematology
- Review Advisory Committee
- HE
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| JPK | Mixture, Hematology Quality Control | FDA class 2 | Hematology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (JPK), ordered by most recent decision date.
XN CHECK BF
FDA 510(k)
FDA Class 2
·Hematology
XN-L CHECK
FDA 510(k)
FDA Class 2
·Hematology
XN CHECK
FDA 510(k)
FDA Class 2
·Hematology
BC-5D Hematology Control
FDA 510(k)
FDA Class 2
·Hematology
XN CHECK BF
FDA 510(k)
FDA Class 2
·Hematology
XN CHECK
FDA 510(k)
FDA Class 2
·Hematology
Other Clearances by Aalto Scientific, Ltd.
| K Number | Device Name | ||
|---|---|---|---|
| K163629 | Audit MicroControls Linearity FD Tumor Markers II | Mar 10, 2017 | Substantially Equivalent |
| K161874 | Audit MicroControls Linearity DROP LQ Blood Glucose | Aug 10, 2016 | Substantially Equivalent |
| K143571 | Audit MicroControls Linearity LQ Cystatin-C | Jan 23, 2015 | Substantially Equivalent |
| K143573 | Audit MicroControls Linearity FD Tumor Markers II | Jan 16, 2015 | Substantially Equivalent |
| K143026 | Audit MicroControls Linearity FD Unsaturated Iron Binding Capacity | Nov 21, 2014 | Substantially Equivalent |
| K142978 | Audit MicroControls Linearity LQ Special Diabetes | Nov 20, 2014 | Substantially Equivalent |
| K130762 | AUDIT MICROCV THERAPEUTIC DRUG (TDM) LINEARITY SET | Apr 29, 2013 | Substantially Equivalent |
| K130764 | AUDIT MICROCV VITAMIN D LINEARITY SET | Apr 26, 2013 | Substantially Equivalent |
| K130157 | AUDIT MICROCV BETA-HYDROXYBUTYRIC ACID LINEARITY SET | Mar 19, 2013 | Substantially Equivalent |
| K112742 | AUDIT MICROLQ SPINAL FLUID CONTROL | Jun 15, 2012 | Substantially Equivalent |